Business
Open Orphan presenting at virtual Investor Foru...
Open Orphan presenting at virtual Investor Foru....
About this update from Hvivo Plc
[{"type":"text","content":"\n \n\n\nHardman & Co Research\n\n\n\nHardman & Co Research: Open Orphan presenting at virtual Investor Forum on 9th July 202017-Jun-2020 / 09:32 GMT/BST\n\n\nHardman & Co Research: Open Orphan presenting at virtual Investor Forum on 9th July 2020\n\nWe are delighted to announce that Open Orphan will be presenting at our next Investor Forum on Thursday 9th July. The Investor Forum connects investors with companies looking for capital. Each company will present for 10-15 minutes, followed by an opportunity for Q&A. \n\nOpen Orphan (ORPH) is a publicly traded company on the London AIM and Euronext Growth stock exchanges. The company was founded in 2017 with the aim of becoming a leading specialist CRO pharmaceutical services business. It has a focus on rare disease/orphan drugs, and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. Open Orphan is comprised of two commercial specialist CRO services businesses, hVIVO and Venn Life Sciences; and has offices in London, Dublin, Paris and the Netherlands. The company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. It also provides digital data platforms to support companies in research & development and commercialisation.\n\nhttps://www.hardmanandco.com/july-2020-virtual-investor-forum/\n\nIf you are interested in attending the virtual forum, you can register your interest by clicking on the above link.\n\n\n To contact us:\n\n Hardman & Co35 New Broad StreetLondonEC2M 1NH\n\n www.hardmanandco.com\n\n Follow us on Twitter @HardmanandCo\n \n \n Contact:\n\n Larissa Adams+44 20 7194 7622\n \n \n \n\n [email protected] \n \n Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.\n\nAbout Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge...